comparemela.com

Page 3 - Prnewswire Akebia Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United statesUnited kingdomPrnewswire akebia therapeutics incAkebia therapeutics incNasdaq listing rule

Akebia Therapeutics to Present at Jefferies Healthcare Conference

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United statesNew yorkUnited kingdomJohn butlerPrnewswire akebia therapeutics incDrug administrationAkebia therapeutics incChief executive officerJefferies healthcare conferenceEuropean summaryProduct characteristicsAkebia therapeutics

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United statesUnited kingdomAkebia therapeutics incPrnewswire akebia therapeutics incNasdaq listing ruleAkebia therapeutics

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four. | June 10, 2023

United statesUnited kingdomMercedes carrascoAkebia therapeutics incPrnewswire akebia therapeutics incNasdaq listing rule

Akebia Therapeutics Announces Adjournment of Special Meeting of Stockholders

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United statesUnited kingdomExchange commission onPrnewswire akebia therapeutics incAkebia therapeutics incExchange commissionSpecial meetingAkebia therapeuticsSecurities litigation reform actAnnual report

vimarsana © 2020. All Rights Reserved.